Latest Strategy Changes News

Proteomics International secures a key Medicare reimbursement rate for its PromarkerD test, a predictive diagnostic for diabetic kidney disease, marking a critical step in its US commercial rollout.

Sky Metals is fast-tracking its drilling program at the Tallebung Tin Project by mobilising a second rig to test high-grade silver-tin zones and expand its resource base. Early assay results are expected in December, setting the stage for an updated Mineral Resource Estimate next year.

Alma Metals Limited has announced a Share Purchase Plan offering eligible Australian and New Zealand shareholders the chance to buy new shares at a 15% discount, aiming to bolster its capital base ahead of year-end.

Keybridge Capital Limited is navigating a complex recovery with new board leadership, partial loan repayments, and favorable court rulings against former executives. The company is steadily addressing legacy financial and legal challenges.

Western Mines Group advances deep diamond drilling and a high-powered electromagnetic survey at its Mulga Tank project, leveraging co-funded grants to target high-grade nickel sulphide deposits.

Beacon Minerals Limited reports a substantial 276% increase in gold resources alongside strategic exploration and development plans, setting the stage for extended mine life and shareholder returns.

Axel REE Limited reports promising metallurgical results from its Caladão Project in Brazil, confirming a magnet-rich ionic clay system with rare earth grades comparable to established Asian operations. These findings underpin a low-capital, low-operating cost in-situ leach development strategy.

Blue Star Helium reports substantial progress on its Galactica helium facility, maintaining its target for first production in December 2025. Key construction and equipment milestones have been achieved, signaling a critical phase in the project’s development.

Select Harvests Limited reported a robust FY2025 with a 32.4% almond price surge driving a $30.9 million NPAT increase and halving net debt. The company’s strategic investments and operational efficiencies position it well for a positive FY2026 outlook.

Select Harvests has reported a striking turnaround in FY2025, with net profit soaring to $31.8 million driven by higher almond prices and operational efficiency, while halving its net debt.

Select Harvests Limited delivered a robust FY2025 with net profit soaring to $31.8 million and net debt slashed by over 50%, despite a smaller almond crop. Strategic investments in processing and sales underpin a confident outlook.

Syntara Limited has successfully completed Phase 1a trials for its topical anti-fibrotic drug SNT-9465, demonstrating dose-dependent target engagement and safety, and is now progressing to an innovative Phase 1b study in hypertrophic scars.